Results 161 to 170 of about 14,467 (291)

Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis

open access: yesDrug Development Research, Volume 87, Issue 8, December 2026.
ABSTRACT Multiple sclerosis is a chronic inflammatory autoimmune disease resulting in progressive demyelination of the central nervous system, leading to symptoms such as motor discoordination, cognitive deficits, and ocular dysfunction. Oxidative stress is a crucial component in the pathogenesis of multiple sclerosis, with reactive oxygen species ...
Arnav Borole   +3 more
wiley   +1 more source

Identification of GPAT acyltransferases in cork oak

open access: yesBMC Proceedings, 2011
Marum Liliana   +3 more
doaj   +1 more source

Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 6, December 2026.
ABSTRACT Pathological cardiac hypertrophy is initially an adaptive response to sustained mechanical, neurohormonal, or metabolic stress; however, it can progress to fibrosis, contractile dysfunction, arrhythmia, and heart failure. Ferroptosis is a type of regulated cell death caused by iron‐dependent phospholipid peroxidation.
Pengbo Liu, Yongzhi Deng
wiley   +1 more source

Predicting the alternative conformation of a known protein structure based on the distogram of AlphaFold2

open access: yesQuantitative Biology, Volume 14, Issue 4, December 2026.
Abstract AlphaFold2 (AF2) has become one of the most established and leading tools for predicting protein structures, although it often favors a single conformation. While it has been shown that sampling different conformations is possible by manipulating the multiple sequence alignment (MSA), the potential for multi‐state information within a standard
Jiaxuan Li, Zefeng Zhu, Chen Song
wiley   +1 more source

A bacterial family of fatty acid acyltransferases related to the <i>Shigella</i> effector IcsB. [PDF]

open access: yesmBio
Bajunaid W   +6 more
europepmc   +1 more source

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 10961-10976, December 2026.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest   +3 more
wiley   +1 more source

Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11796-11807, December 2026.
ABSTRACT Aims Use of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 1 diabetes (T1D) is limited by increased risk of ketoacidosis. We aimed to determine metabolic pathways affected by SGLT2i treatment in adults with T1D during ketosis induced by insulin withdrawal.
Rosa Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy